A pilot randomized trial on safety and efficacy of a novel topical combined inhibitor of janus kinase 1/3 and spleen tyrosine kinase for GVHD-associated ocular surface disease

Ahmad Kheirkhah, Antonio Di Zazzo, Vannarut Satitpitakul, Merle Fernandez, Daniel Magilavy, Reza Dana

Resultado de la investigación: Articlerevisión exhaustiva

17 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'A pilot randomized trial on safety and efficacy of a novel topical combined inhibitor of janus kinase 1/3 and spleen tyrosine kinase for GVHD-associated ocular surface disease'. En conjunto forman una huella única.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science